[Ever Supreme-KY] Announcement Regarding the Appointment of New Co-CEO
Key facts
- [Ever Supreme-KY] Announcement Regarding the Appointment of New Co-CEO
- Ever Supreme-KY announced on May 29, 2026, that the Board of Directors has appointed Lu Kung-ming, Chairman of Shinyo Biotech Investment, as the new Co-CEO.
- Source: PR Times
- Date: May 29, 2026
Direct answer
Ever Supreme-KY announced on May 29, 2026, that the Board of Directors has appointed Lu Kung-ming, Chairman of Shinyo Biotech Investment, as the new Co-CEO.
- Citation
- [Ever Supreme-KY] Announcement Regarding the Appointment of New Co-CEO (May 29, 2026), PR Times
- Source
- PR Times
- Date
- May 29, 2026
Ever Supreme-KY announced on May 29, 2026, that the Board of Directors has appointed Lu Kung-ming, Chairman of Shinyo Biotech Investment, as the new Co-CEO.
📋 Article Processing Timeline
- 📰 Published: May 29, 2026 at 09:00
- 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:12 (34h 12m after Collected)
1. Date of Board resolution or date of change: 2026/05/29
2. Position (Chairman or General Manager): Co-CEO
3. Name of predecessor: Not applicable
4. Resume of predecessor: Not applicable
5. Name of successor: Lu Kung-ming
6. Resume of successor: Chairman of Shinyo Biotech Investment Co., Ltd.
7. Circumstances of change (Resignation, Dismissal, Expiration of term, Job adjustment, Layoff, Retirement, Death, or New appointment): New appointment
8. Reason for change: New appointment
9. Effective date of appointment: 2026/05/29
10. Other matters (If the subject of the event or resolution is a publicly listed company, this major message meets the requirements of Article 7, Paragraph 6 of the Enforcement Rules of the Securities and Exchange Act regarding significant impact on shareholder equity or securities prices): None
2. Position (Chairman or General Manager): Co-CEO
3. Name of predecessor: Not applicable
4. Resume of predecessor: Not applicable
5. Name of successor: Lu Kung-ming
6. Resume of successor: Chairman of Shinyo Biotech Investment Co., Ltd.
7. Circumstances of change (Resignation, Dismissal, Expiration of term, Job adjustment, Layoff, Retirement, Death, or New appointment): New appointment
8. Reason for change: New appointment
9. Effective date of appointment: 2026/05/29
10. Other matters (If the subject of the event or resolution is a publicly listed company, this major message meets the requirements of Article 7, Paragraph 6 of the Enforcement Rules of the Securities and Exchange Act regarding significant impact on shareholder equity or securities prices): None
FAQ
Where can I find the official filing for this appointment?
The filing is available on the Taiwan Stock Exchange (TWSE) Market Observation Post System.
What are the key facts in this article?
Ever Supreme-KY announced on May 29, 2026, that the Board of Directors has appointed Lu Kung-ming, Chairman of Shinyo Biotech Investment, as the new Co-CEO.
What is the direct answer?
Ever Supreme-KY announced on May 29, 2026, that the Board of Directors has appointed Lu Kung-ming, Chairman of Shinyo Biotech Investment, as the new Co-CEO.